Back
POET Technologies Vs. Summit Therapeutics Industry Stock Comparison
Sell
36
POET
POET Technologies
Last Price:
3.10
Seasonality Move:
-20.8%
Buy
79
SMMT
Summit Therapeutics
Last Price:
25.12
Seasonality Move:
26.72%
Sell
36
POET Technologies (POET)
is a Sell
Is POET Technologies a Buy, Sell or Hold?
- The current POET Technologies [POET] share price is $3.10. The Score for POET is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- POET is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
79
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $26.22. The Score for SMMT is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
POET Stock Price Chart
What is POET Technologies's stock price today?
-
The POET Technologies share price today is $3.10
The current trend is moderately bullish and POET is experiencing selling pressure, which indicates risk of future bearish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $26.22
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
POET Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 54.96 | Buy |
| Chaikin Money Flow: | -973939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.83 - 3.17) | Buy |
| Bollinger Bands (100): | (2 - 3.1) | Buy |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.4 | Buy |
| Relative Strength Index (14 RSI): | 69.61 | Buy |
| Chaikin Money Flow: | -7453022 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.89 - 22.53) | Buy |
| Bollinger Bands (100): | (4.23 - 14.99) | Buy |
POET Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.01 | Buy |
| 20-day SMA: | 3.05 | Buy |
| 50-day SMA: | 2.96 | Buy |
| 200-day SMA: | 1.86 | Buy |
| 8-day EMA: | 3.05 | Buy |
| 20-day EMA: | 3 | Buy |
| 50-day EMA: | 2.84 | Buy |
| 200-day EMA: | 2.41 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.01 | Buy |
| 20-day SMA: | 17.36 | Buy |
| 50-day SMA: | 13.03 | Buy |
| 200-day SMA: | 6.61 | Buy |
| 8-day EMA: | 24.48 | Buy |
| 20-day EMA: | 19.28 | Buy |
| 50-day EMA: | 14.43 | Buy |
| 200-day EMA: | 8.04 | Buy |
POET Technologies Earnings Growth & POET Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.02 per share, an increase this year of $0.09 per share, and an increase next year of $0.11 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
POET Technologies Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||